|
American Academy of Pediatrics (AAP) Committee on Genetics
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD
|
The APP Committee on Genetics (COG) studies and makes recommendations to the AAP Board of Directors on recent advances in genetics and provides support to chapters on state legislative issues as they relate to genetics.
|
|
American Academy of Pediatrics (AAP) Committee on Pediatric AIDS
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD
|
The AAP Committee on Pediatric AIDS (COPA) provides guidelines and recommendations for the care and treatment of infants, children, and adolescents with HIV and their families through the development of AAP Policy Statements and the provision of guidance and consultation to other policy making bodies as well as to local and federal governances.
|
|
American Academy of Pediatrics (AAP) Council on Injury, Violence and Poison Prevention (COIVPP)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD
|
The AAP Council on Injury, Violence, and Poison Prevention, was formed on July 1, 2011, with the merging of the former Section and Committee on Injury, Violence, and Poison Prevention. This new leadership body addresses all facets of injury prevention policy, programs, advocacy, and education of general pediatricians, pediatric subspecialists, and families as a unified group.
|
|
American Academy of Pediatrics (AAP) Disaster Activity Council, Federal Liaison
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NICHD
|
The American Academy of Pediatrics (AAP) created the Disaster Preparedness Advisory Council (DPAC) in May 2007 to develop and implement a strategic plan for disaster preparedness and oversee/support AAP disaster preparedness initiatives while working collaboratively with AAP committees, sections, and councils and key partner organizations.
|
|
American Academy of Pediatrics (AAP) Task Force on SIDS
|
Other
|
CDC
|
NICHD
|
The American Academy of Pediatrics appointed the Task Force on SIDS in 1990 to provide evidence-based practice recommendations regarding SIDS risk reduction. Members of the Task Force on SIDS are selected and approved by the Board of Directors and The Executive Committee of the AAP based on their expertise of SIDS and infant mortality
|
|
American Community Survey (ACS) Content Review Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NICHD
|
The American Community Survey (ACS) is an ongoing survey that provides vital information on a yearly basis about our nation and its people. Information from the survey generates data that help determine how more than $400 billion in federal and state funds are distributed each year. Public officials, planners, and entrepreneurs use this information to assess the past and plan the future.
|
|
American Conference for the Treatment of HIV (ACTHIV)
|
Meeting/ Workshop
|
CDC, FDA, HRSA
|
OD/DPCPSI/OAR
|
The American Conference for the Treatment of HIV (ACTHIV) is a state-of-the-science conference for frontline health care professionals, in scientific collaboration with multiple federal and independent agencies. The conference is designed for all frontline clinicians providing HIV care for various population groups.
|
|
Americas Region Interagency Coordination Group on Zika Virus
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NICHD, NIAID, NIEHS
|
This committee was established to allow for information exchange among federal agencies involved with addressing the Zika virus.
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NINDS, NCATS, NCI, NIAAA, NIDA
|
The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the US Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health.
|
|
Anti-Infective Drugs Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
The Committee reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of infectious diseases and disorders and make appropriate recommendations to the FDA Commissioner.
|